Repositioning Candidate Details

Candidate ID: R0513
Source ID: DB01401
Source Type: approved
Compound Type: small molecule
Compound Name: Choline magnesium trisalicylate
Synonyms: --
Molecular Formula: C26H29MgNO10
SMILES: [Mg++].C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O
Structure:
DrugBank Description: Choline magnesium trisalicylate is a non-acetylated salicylate used widely as a nonsteroidal anti-inflammatory drug. Trisalicylate significantly reduces methotrexate renal clearance, displacing methotrexate from protein, increasing the fraction unbound by 28% .
CAS Number: 64425-90-7
Molecular Weight: 539.814
DrugBank Indication: Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults.
DrugBank Pharmacology: Trisalicylate-choline is a non-steroidal anti-inflammatory drug (NSAID) that contains a combination of choline salicylate and magnesium salicylate. Does not affect platelet aggregation.
DrugBank MoA: Inhibits prostaglandin synthesis; acts on the hypothalamus heat-regulating center to reduce fever; blocks the generation of pain impulses
Targets: Prostaglandin G/H synthase 1 inhibitor; Prostaglandin G/H synthase 2 inhibitor
Inclusion Criteria: Therapeutic strategy associated